James Heward Email

Principal Scientist . Nucleome Therapeutics

Current Roles

Employees:
56
Revenue:
$8.7M
About
NUCLEOME THERAPEUTICS is an exciting new venture that just spun out from a decade of research at Oxford University with the aim to unlock the non-coding part of the genome to help deliver life changing treatments. We are building a passionate, creative and dedicated multi-disciplinary team of scientists with expertise in gene regulation, genomics, machine learning, data analysis and software developers, whose mission is to decode and mine the regulatory “dark matter” of the human genome to transform drug target discovery and help deliver the next generation of genetically guided therapeutics. We are building a rewarding and fun environment where people embrace creative ways of thinking, take smart risks, and feel empowered to make a difference.
Nucleome Therapeutics Address
Oxford Science Park
Oxford, null
Nucleome Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.